India may get AstraZeneca vaccine for corona virus by January
The head of an Indian company contracted to make the AstraZeneca vaccine said that the vaccine could reach Corona warriors and elderly Indians by January. Because cases of corona infection are increasing rapidly. Serum Institute of India, the world's largest vaccine manufacturer, has already produced millions of doses of vaccine to be developed in collaboration with Oxford University, while the results of late-morning trials are awaited.
AstraZeneca of Britain has signed supply and manufacturing deals with companies and governments around the world. Data published in the medical journal The Lancet suggest that AstraZeneca vaccine produced a strong immune response in older adults. Pfizer Inc. and Modern Inc. have also released data from the final tests. Their vaccines show more than 90 percent effect. India is tracking the progress of Pfizer and Modern vaccines.
At the same time, American pharmaceutical company Pfizer said on Friday that it has sought approval from US regulators for emergency use of its Corona vaccine. Pfizer Inc. and its German partner BioNotech had earlier announced that a large study showed that their vaccine appears to be up to 95 percent effective in protecting against mild and severe infections of Kovid-19.
The companies said that a good record of safety and safety means vaccines should be given the right to emergency use, which the Food and Drug Administration (FDA) can give before the final investigation is completed. A day before Pfizer's announcement, Dr. Anthony Fauci, an expert on infectious diseases in the country, said that help would come. At the same time, he said that it is not yet time to give up masks and abandon other security measures. He said, we really need to do double the work in public health and we are waiting for that help.